Business Wire

LEAPMOTOR

25.4.2022 09:02:07 CEST | Business Wire | Press release

Share
Leapmotor's First Mass Production Model With CTC Technology

On February 25, 2022, Leapmotor for the first time announced the highlights of its new model C01. It is an electric mid-to-large-sized sedan developed on its C-Vehicle Platform, and also the first mass production model equipped with CTC battery technology, acceleration to 100 km/h in less than 4 seconds, 5-meter plus length and 700km ultra-long range. It will also further expand the portfolio with a planned launch in Q2 of 2022.

Technological and Natural Aesthetics to Create an Inner "Style"

Leapmotor C01 takes natural aesthetics as the design concept, emphasizing smart mobility experience. The design of C01 is featured with technical elements, offering a comfortable environment while the immersive cabin brings a luxurious experience for young, high-end, urban families.

C01 Key Product Features Unveiled

Because of Leapmotor's full-suite of R&D capabilities, the C01 offers compelling features – CTC technology, acceleration, vehicle length and NEDC range. It is set to become a popular product on the EV market.

NO.1 – Leapmotor’s First Mass Production Model with CTC Technology

CTC (Cell-To-Chassis) is a cutting-edge technology that integrates battery into the chassis, leading to greater shock resistance and improved strength of the vehicle. The C01 offers better handling performance, range and collision safety thanks to the CTC Technology.

0-100 km/h Acceleration in less than 4 seconds — Fastest acceleration among electric sedans within the same class in China, supercar-level performance

Leapmotor C01 has one of the fastest acceleration among electric sedans within the same class in China. It is equipped with "Higher Dimension" intelligent power system, using variable-structured oil-cooled electric drive with up to 1 million kilometers lifespan and the world's top NVH performance and power efficiency, meeting the demand for long range and high performance of EVs. In addition, flush door handle, sportback design, 0.226 ultra-low drag coefficient and 5% reduced vehicle weight will offer better performance.

Vehicle Length of over 5 Meter — Mid-to-large-sized sedan

As a mid-to-large sedan, Leapmotor C01 has a 5-meter plus length, wider rear legroom and large trunk space, offering exceptional comfort.

700km Ultra-long NEDC Range — Meeting long-distance travel needs

The C01 is equipped with a 90kWh ultra-large battery, capable of 700km ultra-long NEDC range, meeting consumer needs for long-distance travel. With penetrated large module scheme and intelligent battery management system can improve battery life, range and overall safety.

Full-suite of R&D capabilities Empowering Innovation

Leapmotor has been committed to growing its portfolio of R&D capabilities, obtaining and declaring 1,474 patents, 939 of which have been approved, and more than 40% of which are innovation patents.

Leapmotor increased its product line in 2021 by releasing the C11 as a mid-sized smart electric SUV, entering the RMB 150,000-200,000 SUV sector that has long been dominated by automakers.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

High-end Aesthetic Brand ‘Lorient’ Gains Global Prestige at IMCAS 20261.2.2026 08:00:00 CET | Press release

Lorient, a premium aesthetic brand, announced that it has drawn global attention at the 27th IMCAS World Congress 2026 in Paris, attracting over 15,000 professionals and demonstrating its leadership in aesthetic innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131322203/en/ Lorient’s low degree of modification delivers a smooth injection experience and high biocompatibility (Image: Lorient) The highlight was a session led by Dr. Jani van Loghem, a globally revered key opinion leader known for establishing international aesthetic safety protocols. His involvement provided a prestigious validation of the technical excellence of Lorient. Alongside him, prominent Korean medical experts Dr. Won Lee and Dr. Do Young Rhee shared clinical insights that drew widespread praise from the international medical community. Central to the academic discussions was Lorient’s "safety-first" philosophy for its premium HA filler ran

Sharjah Ruler Receives Portugal’s Grand Collar of Order of Camões31.1.2026 18:27:00 CET | Press release

His Excellency Marcelo Rebelo de Sousa, President of the Portuguese Republic, awarded His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, the Grand Collar of the Order of Camões (Grande Colar da Ordem de Camões), the highest sovereign cultural order in Portugal. His Highness is the first Arab figure to receive the Order of Camões and the sixth recipient worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131119526/en/ Sharjah Ruler receives Portugal’s Grand Collar of Order of Camões (Photo: AETOSWire) The honour was conferred during a ceremony hosted by the Portuguese President at the Presidential Palace in Lisbon. The event was attended by Sheikha Bodour bint Sultan Al Qasimi, Chairperson of the Sharjah Book Authority, alongside senior officials. The ceremony recognised His Highness’s prominent global stature, as a leading figure in culture, intellectual thought and in

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye